Cello Group (CLL)
18/01/2018 - 09:27 StockMarketWire
Cello Group expects results for the year ended 31 Dec to be in line with forecasts. The group said it traded well in 2017, with...
23/11/2017 - 15:54 RNS
RNS Number: 3967X Cello Group plc 23 November 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Cello Group PLC 1...
31/10/2017 - 11:16 RNS
RNS Number: 1078V Cello Group plc 31 October 2017 Cello Group plc Total Voting Rights In conformity with the FCA's Disclosure and Transparency Rules, Cello Group plc ("Cello" or the "Company") confirms the following: As at 31 October 2017 Cello's issued share capital consists of 105,003,988 ordinary shares of 10 pence each ("Ordinary Shares"). The Company hol...
26/10/2017 - 13:37 RNS
RNS Number: 7452U Cello Group plc 26 October 2017 26 October 2017 Cello Group plc ("Cello" or the "Company") Director/PDMR Shareholding The Company has been notified that, on 26 October 2017, Alistair Shirley, a person closely associated with Jane Shirley, CEO of Cello Health Europe and Cello Health Insight, purchased 2,000 ordinary shares of 10 pence each...
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment